Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1990-7-24
|
pubmed:abstractText |
Niacin (nicotinic acid) is available in several forms, including crystalline preparations and various types of sustained-release preparations. Evidence exists that sustained-release niacin, with respect to both dosage and severity, is more hepatotoxic than crystalline niacin. Three patients who developed hepatitis during treatment with sustained-release niacin were rechallenged with equivalent or higher doses of crystalline niacin, with no evidence of recurring hepatocellular damage. Although the mechanism for niacin-induced hepatitis is unknown, these cases support previous observations that crystalline niacin may be less hepatotoxic than sustained-release preparations in certain patients.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0098-7484
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
11
|
pubmed:volume |
264
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
241-3
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:2355446-Crystallization,
pubmed-meshheading:2355446-Delayed-Action Preparations,
pubmed-meshheading:2355446-Drug-Induced Liver Injury,
pubmed-meshheading:2355446-Female,
pubmed-meshheading:2355446-Humans,
pubmed-meshheading:2355446-Male,
pubmed-meshheading:2355446-Middle Aged,
pubmed-meshheading:2355446-Niacin
|
pubmed:year |
1990
|
pubmed:articleTitle |
Rechallenge with crystalline niacin after drug-induced hepatitis from sustained-release niacin.
|
pubmed:affiliation |
Department of Medicine, University of Alabama, Birmingham.
|
pubmed:publicationType |
Journal Article,
Case Reports,
Research Support, Non-U.S. Gov't
|